Completed
Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer
NCT01669239
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Hospital Clínic de Barcelona Barcelona, Spain
- Hospital Universitario Vall d´Hebron Barcelona, Spain
- Complejo Hospitalario San Pedro de Alcántara Cáceres, Spain
- Hospital Universitari Arnau de Vilanova de Lleida Lleida, Spain